2 Paid Clinical Research Studies in Yuma, Arizona

Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.

Phase3

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

This study will assess the efficacy and safety of capivasertib plus docetaxel versus placebo plus docetaxel in participants with metastatic castration resistant prostate cancer (mC

📍 Research Site — Yuma, Arizona

💵 This study will assess the efficacy and safety of capivasertib plus docetaxel versus placebo plus docetaxel in participa

View Study & Checklist ➔